TG Therapeutics (TGTX) Earnings Date & Reports

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

TGTX is expected to report earnings to rise 609.67% to 21 cents per share on August 05

TG Therapeutics TGTX Stock Earnings Reports

Q2'25

Est.

$0.21

Q1'25

Missed

by $0.13

Q4'24

Beat

by $0.07

Q3'24

Est.

$0.02

Q2'24

Beat

by $0.09

The last earnings report on May 05 showed earnings per share of 2 cents, missing the estimate of 15 cents. With 1.77M shares outstanding, the current market capitalization sits at 5.30B.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+30%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

TGTX